Ivabradine (Procorala) Lowers Cardiovascular Death And Hospitalization Risk For Heart Failure Patients
August 30, 2010 – 1:22 amIvabradine (Procorala), a heart-rate-lowering medication, considerably lowers cardiovascular death and hospitalization risk when added to standard treatment in patients suffering from heart failure and a high heart rate (pulse rate), an Article reveals in the medical journal The Lancet. Details of a clinical trial were presented at the European Society of Cardiology Annual Congress 2010, Stockholm, Sweden…
Find more info about Ivabradine (Procorala) Lowers Cardiovascular Death And Hospitalization Risk For Heart Failure Patients photos videos pictures. read more
Related Info :
Tags: Cardiovascular, Cardiovascular Death, Cardiovascular Risk, Clinical Trial, Congress, death, Failure, Failure Rate, Heart, Heart Failure, Heart Failure Patients, Heart Medication, Heart Photos, Heart Pulse, High Heart Rate, Hospitalization, Ivabradine, Lancet, Lowers, Medical Journal, Medication, Patients, Procorala, Pulse Rate, Risk, Stockholm Sweden
Sorry, comments for this entry are closed at this time.